SCHEMBL6603316

SCHEMBL6603316

CCOC(=O)c1nc2cc(C)c([N+](=O)[O-])cc2nc1OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
MITF O75030 2/20 0.45
LMNA P02545 2/20 0.45
POLB P06746 2/20 0.45
GALR2 O43603 1/20 0.45
HSP90AA1 P07900 1/20 0.45
HPGD P15428 1/20 0.45
XBP1 P17861 1/20 0.45
CCR6 P51684 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
CHEK1 O14757 1/20 0.41
DAPK3 O43293 1/20 0.41
PRKD3 O94806 1/20 0.41
MET P08581 1/20 0.41
PDGFRA P16234 1/20 0.41
FLT1 P17948 1/20 0.41
LTK P29376 1/20 0.41
GRK5 P34947 1/20 0.41
CDK8 P49336 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6376052 1.00 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2MITFLMNAPOLB
SCHEMBL6607045 0.90 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2MITFLMNAPOLB
SCHEMBL6377194 0.88 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MITFLMNAPOLB
SCHEMBL6381602 0.88 GLP1R (0.49) ALDH1A1SMN1; SMN2MITFLMNAPOLB
SCHEMBL6604555 0.88 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MITFLMNAPOLB
SCHEMBL6380676 0.88 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MITFLMNAPOLB
SCHEMBL6605451 0.85 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2MITFLMNAPOLB
SCHEMBL6604561 0.82 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2MITFLMNAPOLB
SCHEMBL6380913 0.79 GRIA1 (0.41) ALDH1A1SMN1; SMN2MITF
SCHEMBL6603534 0.79 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2MITFLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1020453-B1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERIVATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2004-05-19 EP disclosed
US-6348461-B1 CENTRAL NERVOUS SYSTEM ANTAGONIST WITH HETEROCYCLIC SUBSTITUENTS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1020453-A1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERI VATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed